Royce & Associates LP increased its holdings in shares of Analogic Co. (NASDAQ:ALOG) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 576,417 shares of the medical research company’s stock after purchasing an additional 15,469 shares during the quarter. Royce & Associates LP owned 4.62% of Analogic worth $48,275,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Dimensional Fund Advisors LP increased its position in Analogic by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 947,627 shares of the medical research company’s stock valued at $79,364,000 after acquiring an additional 37,066 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in Analogic by 5.4% during the third quarter. Schwab Charles Investment Management Inc. now owns 117,155 shares of the medical research company’s stock valued at $9,812,000 after acquiring an additional 6,029 shares during the last quarter. Trexquant Investment LP increased its position in Analogic by 108.9% during the third quarter. Trexquant Investment LP now owns 7,937 shares of the medical research company’s stock valued at $665,000 after acquiring an additional 4,137 shares during the last quarter. Legal & General Group Plc increased its position in Analogic by 6.8% during the third quarter. Legal & General Group Plc now owns 25,362 shares of the medical research company’s stock valued at $2,125,000 after acquiring an additional 1,613 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in Analogic by 10.6% during the third quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock valued at $29,703,000 after acquiring an additional 34,021 shares during the last quarter. 97.61% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Analogic Co. (ALOG) opened at $80.65 on Thursday. The company has a market capitalization of $1,011.88, a price-to-earnings ratio of 48.24, a P/E/G ratio of 4.14 and a beta of 0.86. Analogic Co. has a 1 year low of $66.00 and a 1 year high of $87.60.

Analogic (NASDAQ:ALOG) last posted its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.32. The company had revenue of $106.90 million during the quarter, compared to analysts’ expectations of $100.55 million. Analogic had a positive return on equity of 4.27% and a negative net margin of 15.27%. Analogic’s revenue for the quarter was down 11.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.43 earnings per share. analysts expect that Analogic Co. will post 2.8 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.50%. Analogic’s payout ratio is -6.70%.

A number of analysts recently commented on ALOG shares. Zacks Investment Research upgraded Analogic from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a research report on Tuesday, October 10th. Jefferies Group reiterated a “hold” rating and set a $75.00 price objective on shares of Analogic in a research report on Wednesday, September 20th. Finally, BidaskClub cut Analogic from a “hold” rating to a “sell” rating in a research report on Thursday. One analyst has rated the stock with a sell rating and four have given a hold rating to the stock. Analogic presently has an average rating of “Hold” and an average price target of $85.25.

WARNING: “Analogic Co. (ALOG) Shares Bought by Royce & Associates LP” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/07/analogic-co-alog-shares-bought-by-royce-associates-lp.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.